Canagliflozin attenuates the progression of atherosclerosis and inflammation process in APOE knockout mice

Abstract Background Sodium glucose co-transporter2 inhibitors reduce the incidence of cardiovascular events in patients with type 2 diabetes mellitus based on the results of recent cardiovascular outcome studies. Herein, we investigated the effects of long-term treatment with canagliflozin on bioche...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Νarjes Nasiri-Ansari, Georgios K. Dimitriadis, Georgios Agrogiannis, Despoina Perrea, Ioannis D. Kostakis, Gregory Kaltsas, Athanasios G. Papavassiliou, Harpal S. Randeva, Eva Kassi
Natura: Artigo
Lingua:Inglês
Pubblicazione: BMC 2018-07-01
Serie:Cardiovascular Diabetology
Soggetti:
Canagliflozin
SGLT2i
Atherosclerosis
Inflammation
APOE knockout mice
Accesso online:http://link.springer.com/article/10.1186/s12933-018-0749-1
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi